These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8770780)

  • 1. Sleep in older women with Parkinson's disease.
    Dowling GA
    J Neurosci Nurs; 1995 Dec; 27(6):355-7, 360-2. PubMed ID: 8770780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathophysiology, clinical aspects and therapy of sleep disorders in Parkinson disease].
    Högl B; Wetter TC; Trenkwalder C
    Nervenarzt; 2001 Jun; 72(6):416-24. PubMed ID: 11433700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pain Correlates with Sleep Disturbances in Parkinson's Disease Patients.
    Fu YT; Mao CJ; Ma LJ; Zhang HJ; Wang Y; Li J; Huang JY; Liu JY; Liu CF
    Pain Pract; 2018 Jan; 18(1):29-37. PubMed ID: 28371220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cabergoline added to levodopa treatment on sleep-wake cycle in idiopathic Parkinson's disease: an open label 24-hour polysomnographic study.
    Romigi A; Stanzione P; Marciani MG; Izzi F; Placidi F; Cervellino A; Giacomini P; Brusa L; Grossi K; Pierantozzi M
    J Neural Transm (Vienna); 2006 Dec; 113(12):1909-13. PubMed ID: 16736238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinson's disease and sleep.
    Poewe W; Högl B
    Curr Opin Neurol; 2000 Aug; 13(4):423-6. PubMed ID: 10970059
    [No Abstract]   [Full Text] [Related]  

  • 6. Excessive daytime sleepiness in patients with Parkinson's disease: a polysomnography study.
    Shpirer I; Miniovitz A; Klein C; Goldstein R; Prokhorov T; Theitler J; Pollak L; Rabey JM
    Mov Disord; 2006 Sep; 21(9):1432-8. PubMed ID: 16773617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between dopaminergic medications and nocturnal sleep in early-stage Parkinson's disease.
    Chahine LM; Daley J; Horn S; Duda JE; Colcher A; Hurtig H; Cantor C; Dahodwala N
    Parkinsonism Relat Disord; 2013 Oct; 19(10):859-63. PubMed ID: 23751512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sleep and activity rhythms are related to circadian phase in the blind.
    Lockley SW; Skene DJ; Butler LJ; Arendt J
    Sleep; 1999 Aug; 22(5):616-23. PubMed ID: 10450596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of REM sleep behavior disorder in Parkinson's disease.
    Nomura T; Inoue Y; Kagimura T; Nakashima K
    Sleep Med; 2013 Feb; 14(2):131-5. PubMed ID: 23218532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sleep disruption in Parkinson's disease. Assessment by continuous activity monitoring.
    van Hilten B; Hoff JI; Middelkoop HA; van der Velde EA; Kerkhof GA; Wauquier A; Kamphuisen HA; Roos RA
    Arch Neurol; 1994 Sep; 51(9):922-8. PubMed ID: 8080393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The basis for day and night-time control of symptoms of Parkinson's disease.
    Chaudhuri KR
    Eur J Neurol; 2002 Nov; 9 Suppl 3():40-3. PubMed ID: 12464120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity-rest rhythm abnormalities in Parkinson's disease patients are related to dopaminergic therapy.
    Perez-Lloret S; Rossi M; Cardinali DP; Merello M
    Int J Neurosci; 2010 Jan; 120(1):11-6. PubMed ID: 20128666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sleep disruption, daytime somnolence and 'sleep attacks' in Parkinson's disease: a clinical survey in PD patients and age-matched healthy volunteers.
    Ferreira JJ; Desboeuf K; Galitzky M; Thalamas C; Brefel-Courbon C; Fabre N; Senard JM; Montastruc JL; Sampaio C; Rascol O
    Eur J Neurol; 2006 Mar; 13(3):209-14. PubMed ID: 16618334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When do the symptoms of autonomic nervous system malfunction appear in patients with Parkinson's disease?
    De Luka SR; Svetel M; Pekmezović T; Milovanović B; Kostić VS
    Vojnosanit Pregl; 2014 Apr; 71(4):346-51. PubMed ID: 24783414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are sleep disturbances preclinical markers of Parkinson's disease?
    dos Santos AB; Kohlmeier KA; Barreto GE
    Neurochem Res; 2015 Mar; 40(3):421-7. PubMed ID: 25433714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Night-time sleep in Parkinson's disease - the potential use of Parkinson's KinetiGraph: a prospective comparative study.
    Klingelhoefer L; Rizos A; Sauerbier A; McGregor S; Martinez-Martin P; Reichmann H; Horne M; Chaudhuri KR
    Eur J Neurol; 2016 Aug; 23(8):1275-88. PubMed ID: 27160044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levodopa monotherapy can induce "sleep attacks" in Parkinson's disease patients.
    Ferreira JJ; Thalamas C; Montastruc JL; Castro-Caldas A; Rascol O
    J Neurol; 2001 May; 248(5):426-7. PubMed ID: 11437169
    [No Abstract]   [Full Text] [Related]  

  • 18. Sleep and sleepiness in patients with Parkinson's disease before and after dopaminergic treatment.
    Kaynak D; Kiziltan G; Kaynak H; Benbir G; Uysal O
    Eur J Neurol; 2005 Mar; 12(3):199-207. PubMed ID: 15693809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circadian and sleep disorders in Parkinson's disease.
    Videnovic A; Golombek D
    Exp Neurol; 2013 May; 243():45-56. PubMed ID: 22935723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sleep disorders and their determinants in multiple system atrophy.
    Ghorayeb I; Yekhlef F; Chrysostome V; Balestre E; Bioulac B; Tison F
    J Neurol Neurosurg Psychiatry; 2002 Jun; 72(6):798-800. PubMed ID: 12023429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.